Open access · CC-BY
via OpenAlex
Culturing human pluripotent stem cells for regenerative medicine
Hiroki Ozawa, Takuya Matsumoto, Masato Nakagawa
Expert Opinion on Biological Therapy · 2023 · ▲ 15 citations
Abstract
INTRODUCTION: The development of human pluripotent stem cell (hPSC) culture protocols has led to the establishment of directed differentiation induction methods, resulting in their application in regenerative medicine. Cell therapy products derived from hPSCs have been transplanted into patients, and promising results have been observed in some ongoing clinical trials. AREA COVERED: This review provides an overview of the challenges associated with the culture of hPSCs for clinical applications and the development of culture technologies designed to address these challenges. We also review future cell culture strategies for large-scale manufacturing to enhance patient access. EXPERT OPINION: Despite the great potential of hPSCs, difficulties such as safety, quality control, and cost management continue to pose obstacles to their product development and clinical translation. A substantial contribution of these issues lies in the cell culture process. Therefore, selecting the appropriate ancillary materials (AMs) and integrating effective culture methods in standard operating procedures (SOPs) from the early stages of clinical development are essential for success. Moreover, incorporating an automated scaling process is imperative to ensure the commercial feasibility of hPSC-based products. [Figure: see text]Human pluripotent stem cells (hPSCs) show great potential as a valuable resource for regenerative medicine. However, three significant obstacles must be overcome: safety, quality, and costs. Thankfully, recent progress in hPSC culture techniques has effectively tackled these challenges, opening up exciting possibilities for realizing hPSC-based regenerative medicine.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1080/14712598.2023.2225701
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
Ozawa, H., Matsumoto, T., & Nakagawa, M. (2023). Culturing human pluripotent stem cells for regenerative medicine. <em>Expert Opinion on Biological Therapy</em>. https://doi.org/10.1080/14712598.2023.2225701
Vancouver
Ozawa H, Matsumoto T, Nakagawa M. Culturing human pluripotent stem cells for regenerative medicine. Expert Opinion on Biological Therapy. 2023. doi:10.1080/14712598.2023.2225701.
BibTeX
@article{hiroki2023Cultur,
title = {Culturing human pluripotent stem cells for regenerative medicine},
author = {Hiroki Ozawa and Takuya Matsumoto and Masato Nakagawa},
journal = {Expert Opinion on Biological Therapy},
year = {2023},
doi = {10.1080/14712598.2023.2225701},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Annals of the New York Academy of Sciences 2006
Citation only
Stem Cells: Potential Therapy for Age‐Related Diseases
International Journal of Medical Sciences 2017
Open access · CC-BY
Ethical and Safety Issues of Stem Cell-Based Therapy
Cell Medicine 2018
Open access · CC-BY
The effect of age on stem cell function and utility for therapy
Astana Medical Journal 2026
Open access · OA
Mesenchymal Stem Cells in Regenerative Therapy: Therapeutic Potential and Applications
Mechanisms of Ageing and Development 2021
Open access · CC-BY
Strategies for late phase preclinical and early clinical trials of senolytics
Cell Cycle 2005
Open access · OA